Human Intestinal Microbiota and Type 1 Diabetes Outi Vaarala Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor) 10 August 2013 Pages: 601 - 607
Novel Diabetes Autoantibodies and Prediction of Type 1 Diabetes Janet M. WenzlauJohn C. Hutton Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor) 31 July 2013 Pages: 608 - 615
Antigen-Based Vaccination and Prevention of Type 1 Diabetes Leonard C. HarrisonJohn M. WentworthGrant Morahan Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor) 27 July 2013 Pages: 616 - 623
Epigenetic Regulation of Pancreatic Islets Cecile Haumaitre Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor) 02 August 2013 Pages: 624 - 632
Candidate Genes Expressed in Human Islets and Their Role in the Pathogenesis of Type 1 Diabetes Joachim StorlingCaroline Anna Brorsson Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor) 08 August 2013 Pages: 633 - 641
The Changing Landscape of Type 1 Diabetes: Recent Developments and Future Frontiers Kendra VehikNadim J. AjamiBrant R. Burkhardt Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor) 03 August 2013 Pages: 642 - 650
Is Autoimmunity or Insulin Resistance the Primary Driver of Type 1 Diabetes? Terence J. Wilkin Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor) 05 September 2013 Pages: 651 - 656
Continuous Glucose Monitoring: Current Use and Future Directions Daniel DeSalvoBruce Buckingham Treatment of Type 1 Diabetes (JR Unger, Section Editor) 14 August 2013 Pages: 657 - 662
Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes Jeff Unger Treatment of Type 1 Diabetes (JR Unger, Section Editor) 17 August 2013 Pages: 663 - 668
Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention Omodele AwoniyiRabia RehmanSamuel Dagogo-Jack Treatment of Type 1 Diabetes (JR Unger, Section Editor) 04 August 2013 Pages: 669 - 678
Screening, Prevention, and Ambitious Management of Diabetic Macular Edema in Patients with Type 1 Diabetes Ryan M. TarantolaRaj K. MaturiSunil Gupta Treatment of Type 1 Diabetes (JR Unger, Section Editor) 20 August 2013 Pages: 679 - 686
Transplantation of Xenogeneic Islets: Are We There Yet? Philip J. O’ConnellPeter J. CowanAndrew M. Lew Transplantation (A Pileggi, Section Editor) 07 August 2013 Pages: 687 - 694
Making β Cells from Adult Cells Within the Pancreas Philippe A. LysyGordon C. WeirSusan Bonner-Weir Transplantation (A Pileggi, Section Editor) 08 August 2013 Pages: 695 - 703
Immune Monitoring of Islet and Pancreas Transplant Recipients J. R. F. AbreuB. O. Roep Transplantation (A Pileggi, Section Editor) 13 August 2013 Pages: 704 - 712
Biologic Agents in Islet Transplantation Boris Gala-LopezAndrew R. PepperA. M. James Shapiro Transplantation (A Pileggi, Section Editor) 07 August 2013 Pages: 713 - 722
Use of Glucagon-Like Peptide-1 Agonists to Improve Islet Graft Performance Yong WangMeirigeng QiJose Oberholzer Transplantation (A Pileggi, Section Editor) 08 August 2013 Pages: 723 - 732
Anti-Inflammatory Strategies to Enhance Islet Engraftment and Survival Antonio CitroElisa CantarelliLorenzo Piemonti Transplantation (A Pileggi, Section Editor) 04 August 2013 Pages: 733 - 744
Bioengineered Sites for Islet Cell Transplantation Sophie VériterPierre GianelloDenis Dufrane Transplantation (A Pileggi, Section Editor) 20 August 2013 Pages: 745 - 755